Imre D Noth, MD
Pulmonary Critical Care
Additional Locations
Bio & Overview
Imre Noth, MD, joined UVA in February 2018 as the chief of the Division of Pulmonary and Critical Care Medicine. He received his bachelor of arts from the University of Pennsylvania, followed by a master of science in human physiology at Georgetown University and a medical degree from the University of Arizona College of Medicine. Noth completed a residency in internal medicine at the University of California at Davis Medical Center in Sacramento, California. He then pursued a pulmonary and critical care fellowship at the University of Chicago, where upon completion in 1999, he joined the faculty. Noth rose to the rank of professor of medicine at the University of Chicago in 2012.
A premiere translational researcher, Noth is an expert in clinical trial design, genomics, transcriptomics and pharmacogenomics. Over the last decade and a half, he has concentrated his research efforts on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis (IPF). He built one of the country’s largest subspecialty clinics in interstitial lung diseases. The accompanying bio-repository enabled his translational investigation in genetics and genomics of IPF.
Noth has participated and remains principal investigator for numerous clinical trials funded by the industry, the National Heart Lung and Blood Institute and the National Institutes of Health, which focus predominantly on IPF. He is the co-lead of the NIH-sponsored Protocol Leadership Group for IPF in the Pulmonary Clinical Trials Consortium. His research goal is for true precision and personalized medicine to generate potential therapies for this devastating disease.
In his free time, Noth enjoys spending time with his wife and three children. He has also traveled extensively and hopes to continue to do so.
Academic Information
- Department
- Medicine
- Academic Role
- Professor
- Division
- Pulmonary Critical Care
- Research Interests
- Idiopathic pulmonary fibrosis genetics, genomics and clinical trials
- Gender
- Male
- Languages
- Hebrew, English
- Age Groups Seen
- Adults (21-65)
Older Adults (65+)
- Primary Education
- University of Arizona College of Medicine
- Residency
- UC Davis
- Fellowships
- University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
- Certification
- American Board of Internal Medicine (Pulmonary Disease)
Highlights
Dr. Imre Noth Video Profile
My name is Imre Noth, and I'm a pulmonary and critical care physician here at UVA. For this stage in my career, I'm actually mostly focused on seeing and treating interstitial lung disease patients in the outpatient setting. Within interstitial lung disease, which is a broad umbrella of uncommon diseases, is something called idiopathic pulmonary fibrosis. It's a pretty deadly disease, on par with how many women die from breast cancer is how many people die from pulmonary fibrosis, to give you some idea. I've had the opportunity to be on the cutting edge in the development of treatments in pulmonary fibrosis, and diagnosis of categorization. And so that's what I'm really known for. Patients should come to an academic center, and UVA in particular, because an academic center is going to offer things that they're not going to be able to get in a private practice. What academic centers bring to the table above and beyond that, and their reason for existence, is really to bring that higher level of sub-specialization that only comes from volume. So, here it is, I take care of rare diseases. You only get good at taking care diseases if you see a lot of them. It's very interesting to discuss what new patients can expect because we're actually building it out. With my arrival, we've refocused the interstitial lung disease program. We're really trying to get them that additional expertise they're not able to get on the outside, and partner with our outside docs.
Reviews
103 Patient Satisfaction Ratings
Our patient satisfaction ratings are an average of all the survey responses to the below questions a provider got within the past 2 years. To protect your privacy, patients aren't identified.
See more about our patient satisfaction surveys .